Lilly launches trial-finding mobile app for cancer patients

Friday, June 1, 2012 03:49 PM

Eli Lilly’s cancer division, Lilly Oncology, has launched a searchable clinical trial mobile application for oncology healthcare professionals.

The app—available for the iPad, iPhone, BlackBerry and Android platforms—allows healthcare professionals to search oncology trials that are enrolling new patients by disease state, molecule being studied, study phase, country, state and keyword.

Because the mobile app provides details on all global oncology trials, the app's functionality also provides a mechanism for the healthcare professional to contact Lilly Oncology for additional details on its trials, as well as a third-party contact for the non-Lilly clinical trials.

"Lilly Oncology created the Clinical Trial Resource mobile app to offer cancer care professionals an easy way to search for and identify details about all global oncology clinical trials—not just those sponsored by Lilly," said Anne White, senior director of portfolio management, Lilly Oncology. "The information will enable physicians to provide the most current study information—quickly—to patients who may be interested in participating in a clinical trial."

Directions for downloading the clinical trial app are available on an also newly-launched website, LillyOncologyPipeline.com, an online resource that will house information on its pipeline of potential cancer and supportive care molecules. Through the new website, healthcare professionals can search for information about Lilly Oncology's pipeline by drug discovery platform, cancer type, clinical trial phase and molecular target. Specific information about each medicine includes illustrations of the target pathway and, when available, video of the pipeline compound's method of action.

Share:          
CWWeekly

June 29

FDA and PatientsLikeMe collaborate to test social media adverse event reporting

Boston-area teaching hospitals launch web portal to attract life science companies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs